Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

sen is

currently in phase 3 development for patients with homozygous familial

hypercholesterolemia, and a U.S. marketing application for this

indication is anticipated in 2009. The product offers an innovative

approach to addressing a real, unmet medical need, and Genzyme believes

it could prove to be the most effective lipid-lowering agent for high

risk cardiovascular disease patients for whom conventional therapies

are not sufficient. The product may potentially provide significant

benefit over the standard of care and targets a well-defined and

severely ill patient population.

Alemtuzumab for multiple sclerosis

-- Genzyme is enrolling patients in two phase 3 trials examining the

safety and efficacy of alemtuzumab for the treatment of multiple

sclerosis. One study includes previously untreated patients and one

involves patients whose disease remains active following treatment with

an approved therapy. Alemtuzumab's effect in treating MS, observed in

clinical studies, exceeds that of any currently marketed products and

any products in development. Genzyme believes that alemtuzumab has the

potential to be the best therapy in a market for MS drugs that is

projected to reach $8-9 billion annually when the treatment is expected

to be ready for launch in 2011-2012. Alemtuzumab is being developed in

collaboration with Bayer Schering Pharma AG, Germany.

Genz-112638 for Gaucher disease

-- Genzyme is investing in the development of an innovative, next-

generation product for the treatment of Gaucher disease. The company

has completed enrollment in a phase 2 trial of the small molecule

Genz-112638, a novel oral therapy that could provide an additional

treatment option for physicians and patients. Initial results for the

first group
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... ... 03, 2015 , ... The Erie County Bar Association Institute ... The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... investigating these types of cases. , Each year, New York State residents are ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location in ... State. The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will ... Amica Insurance is sharing some tips to promote the proper use of ... go to the emergency room daily with fireworks-related injuries in the month surrounding the ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2
... Podcast from Perot Systems on the Role of Information Technology in Improving HealthcarePLANO, Texas, ... Dr. Harry Greenspun, executive vice president and chief, ... Guest: Dr. Nathaniel Hupert, Director of The Preparedness Modeling Unit, ... Centers for Disease Control and Prevention (CDC) and, ...
... their homes is the focus of Penn State,s portion ... that will also test the efficacy of a workplace ... "We,re seeing that stress in the workplace can create ... quality of life in families," says David Almeida, professor ...
... Ian Benjamin Named EBP Practice LeaderNEW YORK, April ... Pullen, LLP announced today a major expansion in ... practice in their New York office. The expansion ... partner with extensive experience in the EBP sector.(Logo: ...
... to Increasing Support for Men,s Health Issues in ... Health Network applauds Representatives Barron Hill (D-IN) and ... the "Men and Families Health Care Act of ... Men,s Health within the Department of Health and ...
... Innovation in the Anthelios Franchise for UVA and UVB ... La Roche-Posay, the company that brought the highly ... the availability of Anthelios 60 Sunscreen(1) beginning May 1st. ... new revolutionary sunscreen range offers high ...
... April 30, 2009 Biogen Idec (NASDAQ: BIIB) today ... (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing ... (Controlled High Risk Subjects AVONEX MS Prevention Study). ... for use in patients who experienced their first clinical ...
Cached Medicine News:Health News:Looking Forward: The Use of Health IT in Crisis 2Health News:Looking Forward: The Use of Health IT in Crisis 3Health News:Looking Forward: The Use of Health IT in Crisis 4Health News:Penn State plays integral role in $35 million stress project 2Health News:RSM McGladrey and McGladrey & Pullen LLP Announce Major Expansion of Employee Benefits Plan Practice in New York 2Health News:RSM McGladrey and McGladrey & Pullen LLP Announce Major Expansion of Employee Benefits Plan Practice in New York 3Health News:U.S. Representatives Hill and Murphy Introduce the 'Men and Families Health Care Act of 2009' 2Health News:Photos: ANTHELIOS 60 Sunscreen(1) with CELL-OX SHIELD(TM) Available May 1 Nationwide 2Health News:Photos: ANTHELIOS 60 Sunscreen(1) with CELL-OX SHIELD(TM) Available May 1 Nationwide 3Health News:First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients 2
(Date:7/3/2015)... , Mexique, July 3, 2015 ... continue cible les épidémies que sont l,hypertension, le ... par l,intermédiaire de plateformes éducatives gratuites et d,une ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... diabète en ligne , Prendre en charge ...
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... SHENZHEN , Chine, 3 juillet 2015 ... séquençage à haut débit de l,ADN situé à ... la certification de  l,American College of Pathologists  (Collège ... BGI à Hong Kong ... nouvelle génération à recevoir la certification du CAP ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... medical disposables and non-woven fabric made from 100% natural PurCotton® ... present at the 2011 Brean Murray, Carret & Co. Beijing ... 28, 2011 at the JW Marriott Hotel located at 83 ...
... OncoSec Medical Incorporated (OTCBB: ONCS), a therapeutic oncology company ... cancers, announced today that Anthony E Maida, III, Ph.D., ... will chair its audit committee. (Logo: ... Dr. Maida has focused on clinical development of immunotherapies ...
Cached Medicine Technology:Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 2Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 3OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 2OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 3
Inquire...
... Sebia's Normal and Hypergamma Controls ... on either agarose gels or ... system. Our unique control manufacturing ... as the other serum components, ...
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Inquire...
Medicine Products: